Jpmorgan Chase & Co »

Oncocyte Corporation shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Oncocyte Corporation (OCX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $438 154 2.85
2024-06-30 $454 154 2.95
2024-03-31 $451 154 2.93
2023-12-31 $381 154 2.48
2023-09-30 $504 154 3.28